icer white paper affordable access to glp-1 obesity medications 2025 A KFF analysis shows that use of and spending for drugs under Medicare grew substantially between 2019 and 2024, reflecting their effectiveness in treating type 2 diabetes and other conditions. Medicare Lifetime Social Returns From Expanding
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15


























